No Data
No Data
Dyne Therapeutics Advances Clinical Programs Amid Financial Losses
Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise
DYNE THERAPEUTICS Earnings Results: $DYN Reports Quarterly Earnings
Earnings Flash (DYN) Dyne Therapeutics Reports Q4 Loss $0.88, Vs. FactSet Est of $0.94 Loss
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Dyne Therapeutics Had Cash, Cash Equivalents and Marketable Securities of $642.3M as of Dec 31 >DYN